Cathy Gwin
Senior Director, Communications
News
Media Contact
NTI Welcomes Christine E. Wormuth as President and CEO
A national security leader with more than 30 years of experience in defense policy, strategic planning, and international security, Secretary Wormuth brings an extensive record of leadership and service at the Department of Defense, the White House, and prominent think tanks.
NTI Supports Tech-Driven Solutions to Modernize BWC Compliance
At the UN General Assembly President Trump announced his administration’s intention to harness artificial intelligence to help uphold the international ban on biological weapons. Using advanced technology to strengthen the Biological Weapons Convention is a promising step and an approach NTI has long supported.
NTI at the Biological Weapons Convention: Urging Collective Action to Reduce Biological and AI Risks
NTI’s Global Biological Policy and Programs team will host two side events at the Sixth Session of the Working Group on the Strengthening of the Biological Weapons Convention (BWC).
Apply for the 2025 NTI | bio Next Generation Biosecurity Delegation
Through this opportunity, we seek to foster an energized, internationally connected, and diverse network of next-generation leaders working to strengthen global biosecurity.
HHS Cancellation of Funding for mRNA Vaccines is a Dangerous Mistake that Puts Millions of Lives at Risk
A statement by Jaime M. Yassif, PhD, vice president, NTI Global Biological Policy and Programs.
B-roll North Korean Nuclear Test
B-Roll IRAN Natanz Enrichment Complex
B-roll Rattehalli Materials Plant - India
Stay Informed
Sign up for our newsletter to get the latest on nuclear and biological threats.
